PRESS RELEASE published on 08/22/2023 at 14:00, 2 years 11 months ago PAION launches Byfavo® (remimazolam) in the first European country for General Anesthesia
PRESS RELEASE published on 08/14/2023 at 15:14, 2 years 11 months ago EQS-Adhoc: Tilmann Bur succeeds Gregor Siebert as CEO of PAION AG
PRESS RELEASE published on 07/17/2023 at 10:00, 3 years ago PAION AG: HANA PHARM RECEIVES MARKET APPROVAL FOR BYFAVO IN GENERAL ANESTHESIA IN THE PHILIPPINES
PRESS RELEASE published on 07/12/2023 at 17:10, 3 years ago PAION AG SUCCESSFULLY HOLDS ITS ANNUAL GENERAL MEETING 2023
PRESS RELEASE published on 05/25/2023 at 14:00, 3 years 1 month ago PAION IS HOSTING A SPONSORED BYFAVO® SYMPOSIUM AT EUROANAESTHESIA 2023 IN GLASGOW
PRESS RELEASE published on 05/17/2023 at 07:30, 3 years 2 months ago PAION AG publishes GROUP QUARTERLY STATEMENT for the first quarter of 2023
PRESS RELEASE published on 04/25/2023 at 14:00, 3 years 2 months ago POSTPONEMENT OF PUBLICATION OF THE ANNUAL AND CONSOLIDATED FINANCIAL STATEMENTS 2022
PRESS RELEASE published on 04/03/2023 at 13:20, 3 years 3 months ago EQS-Adhoc: PAION receives European Commission approval of remimazolam for the Induction and maintenance of general anesthesia in adults
PRESS RELEASE published on 03/31/2023 at 19:15, 3 years 3 months ago PAION AG implements resolved capital reduction
PRESS RELEASE published on 03/30/2023 at 07:30, 3 years 3 months ago PAION AG reports on fiscal year 2022
Published on 07/24/2026 at 14:00, 4 hours 10 minutes ago NanoViricides Announces Pricing of ~$3.8 Million Registered Direct Offering
Published on 07/24/2026 at 13:10, 5 hours ago Spirit Blockchain Capital Appoints Suha Askary as Chief Executive Officer
Published on 07/24/2026 at 09:10, 9 hours ago HM Exploration Commences Optical & Acoustic Televiewer Program at the Lewis Pilley's Project
Published on 07/24/2026 at 08:00, 10 hours 10 minutes ago Galantas Announces Amendment to a Dragones Share Purchase Agreement
Published on 07/24/2026 at 05:55, 12 hours 15 minutes ago Alphinat Announces a Loss of $(44,521) for Quarter Ended May 31, 2026
Published on 07/24/2026 at 17:50, 20 minutes ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 07/24/2026 at 17:40, 30 minutes ago 2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of May 31, 2026.
Published on 07/24/2026 at 17:40, 30 minutes ago 2CRSi SA: Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2026.
Published on 07/24/2026 at 16:23, 1 hour 47 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 07/24/2026 at 16:22, 1 hour 48 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 07/24/2026 at 08:45, 9 hours 25 minutes ago BAIKOWSKI : Bilan semestriel du contrat de liquidité au 30 juin 2026
Published on 07/24/2026 at 08:00, 10 hours 10 minutes ago Accor signs a definitive binding agreement on the sale of its stake in Essendi
